Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
Demetris Papamichael, Guilherme S. Lopes, Curt L. Olswold, Jean‐Yves Douillard, Richard Adams, Tim Maughan, Eric Van Cutsem, Alan P. Venook, Heinz‐Josef Lenz, Volker Heinemann, Richard Kaplan, Carsten Bokemeyer, Benoist Chibaudel, Axel Grothey, Takayuki Yoshino, John Zalcberg, Aimery de Gramont, Qian Shi
Topics & Concepts
MedicineHazard ratioInternal medicineColorectal cancerEpidermal growth factor receptorConfidence intervalOncologyProgression-free survivalCancerChemotherapyAdverse effectGastroenterologyEpidermal growth factorReceptorColorectal Cancer Treatments and StudiesAdvanced Breast Cancer TherapiesLung Cancer Treatments and Mutations